Stephan Schmidt

PBAM model and its application in lighter weight pediatric subjects

Optimizing Betamethasone Therapy for Preventing Respiratory Distress Syndrome in Twin Pregnancy

Dose based aspirin pharmacokinetics and pharmacodynamics in pregnancy

GSK UF Fellowship (Jain, 2025-2026)

GSK UF Fellowship (Jain, 2026-2027)

Development of a physiologically based pharmacokinetic model for a new chemical entity (NCE) to evaluate drug-drug interaction potential

Development and verification of mechanism-based translational disease modeling platform for neurodegenerative disorders

Certara - UF Postdoctoral Fellowship (2025)

GSK-UF Fellowship (Walker, 2024-2025)

GSK-UF Fellowship (Walker, 2025- 2026)

Certara - UF Postdoctoral Fellowship

GSK-UF Fellowship Year 1 (2023-2024)

GSK-UF Fellowship funding agreement 2023-24 (Conchon Costa)

GSK-UF Fellowship Year 2 (2024-2025)

Certara-UF PhD Fellowship (Gebhart)

Pain, Multimorbidity, Opioid-Drug Interactions and Risk for Opioid Use Disorder or Overdose in Older Adults

Development of a semi-mechanistic disease-drug platform for hepatitis B

Physiologically-based Pharmacokinetic (PBPK) Modeling of Drug-drug interactions (DDI) for TEV-56268

Certara-UF Summer Intern Fellowship

Model Integrated Evidence Approach for Intravesical Drug Delivery for Localized Bladder Disease

UF Post-doctoral Fellowship Program - Year 1

UF Post-doctoral Fellowship Program - Year 2

Opioid Prescribing Practices and Health Outcomes among Patients with Alzheimer’s Disease and Related Dementia

Development of a physiologically based pharmacokinetic model for levetiracetam to evaluate brain tissue distribution of different drug products (continuation)

A Phase III, Single-arm, Open-label, International, Multi-centre Study to Evaluate the Efficacy and Safety of Lomitapide in Paediatric Patients with Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid-lowering Therapy